I joined Rutgers Cancer Institute of New Jersey in 2017 as Clinical Director of Rutgers Cancer Institute of New Jersey at University Hospital and Assistant Professor of Medicine at Rutgers New Jersey Medical School. In my current role, I am responsible for overseeing the delivery of clinical services for Hematology/Oncology in Newark. Previously, I worked at Hackensack Meridian Health as part of the breast and gynecologic cancer teams providing multidisciplinary care to patients. Prior to this, I spent five years in India as Director of Hematology/Medical Oncology at the Max Group of Hospitals developing their medical oncology and transplant division as part of a comprehensive cancer care program.
With my previous experience in delivering multidisciplinary cancer care, one of my primary focus areas at Rutgers Cancer Institute at University Hospital is the development of multidisciplinary cancer care teams. I have a keen interest in breast cancer and head and neck cancers and am an integral part of both multidisciplinary teams to provide comprehensive patient care and access to the latest treatments for our patients. I believe strongly in patient centric care - treating not just the disease but the patient - addressing all supportive care issues and other concerns in an equally important way.
While in the last few years, I have focused more on the clinical and administrative side of my responsibility, I am working to increase my involvement in research and clinical trials and am involved in the initiation of and development of clinical trials at Rutgers Cancer Institute of New Jersey at University Hospital to offer novel and investigational therapies to patients.I am focused on developing clinical trials for triple negative breast cancer patients to expand therapeutic options for this subset of patients . Combining newer agents with radiation therapy to explore nonconventional treatment avenues for head and neck cancer is another area of focus.
Breast cancer, head and neck cancers, and clinical trials